You're in! See your latest actions or visit profile and dashboard
Account Information
Dashboard
March for Babies Dashboard

  • Preferences
  • Messages
  • Favorites

Statement from the March of Dimes on 17P

, Wednesday, March 30, 2011

save print
e-mail

 MARCH 30, 2011 -- The March of Dimes welcomes today’s FDA statement, which lays to rest any ambiguities about whether specialty pharmacies can continue to compound 17-P. It would be a tragedy to interrupt access to this important drug.

To date, Ther-Rx Corporation’s handling of the launch of Makena has been unsatisfactory to the March of Dimes and to the families we represent. We’ve asked Ther-Rx in writing and in discussion to substantially lower the price of Makena and to expand coverage for patient financial assistance. We’re waiting for their public statement on this matter, which we expect will occur within the next week.

The March of Dimes number one concern is the health of mothers and babies. We will continue to work in a variety of ways to ensure that all medically eligible women have access to progesterone therapy.

For the latest resources and health information, visit our websites marchofdimes.org and nacersano.org. If you have been affected by prematurity or birth defects, visit our shareyourstory.org community to find comfort and support. For detailed national, state and local perinatal statistics, visit persistats.org. You can also find us on Facebook or follow us on Twitter.

Change my location


My ZIP code:
 

Edit my location

Sign in or Sign up to edit location.

[X]

Research breakthroughs

March of Dimes funded research is saving the lives of thousands of babies each year.